Back to Search
Start Over
Comorbidities and polypharmacy among HIV-positive patients aged 50 years and over: a case–control study
Comorbidities and polypharmacy among HIV-positive patients aged 50 years and over: a case–control study
- Source :
- BMC Research Notes, Vol 12, Iss 1, Pp 1-6 (2019)
- Publication Year :
- 2019
- Publisher :
- BMC, 2019.
-
Abstract
- Abstract Objective This study was to determine and compare the prevalences of polypharmacy and comorbidities in patients aged 50 years or older with those patients younger than 50 years in a Mexican population. Results One hundred and twenty-five patients were enrolled, 60 (48%) were aged 50 years or older. The median CD4+ cell counts were 509 cells/μL (interquartile range [IQR]: 324–730) for the older patients and 384 cells/μL (IQR: 262–562) (P = 0.021) for the younger patients. Viral suppression were significantly higher in the older group: 80% vs. 63% (P = 0.037). The number of comorbidities was significantly higher in the older group, with a median of 2 (IQR: 2–3) vs. 1 (IQR: 0–1) (P ≤ 0.001). After adjustment of the logistic regression model in the older group, the following comorbidities differed between the age groups: systemic arterial hypertension (odds ratio [OR]: 15.75; 95% confidence interval [CI] 3.49–71.05; P =
Details
- Language :
- English
- ISSN :
- 17560500
- Volume :
- 12
- Issue :
- 1
- Database :
- Directory of Open Access Journals
- Journal :
- BMC Research Notes
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.3a84bc1e9e3e4735949a9157683dbc96
- Document Type :
- article
- Full Text :
- https://doi.org/10.1186/s13104-019-4576-6